Positions

Overview

  • Global health researcher based in Africa

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.  Clinical Infectious Diseases.  69:1345-1352. 2019
    2019 Changes in rapid hiv treatment initiation after national “treat all” policy adoption in 6 sub-saharan african countries: Regression discontinuity analysis.  PLoS Medicine.  16. 2019
    2019 Hepatitis B Therapy as HIV Prevention in Africa: A Case Series From Zambia.  Hepatology.  69:458-460. 2019
    2018 High prevalence of binge drinking among people living with HIV in four African countries.  Journal of the International AIDS Society.  21. 2018
    2018 Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.  Journal of the International AIDS Society.  21. 2018
    2018 Mental health comorbidity in low-income and middle-income countries: a call for improved measurement and treatment.  Lancet Psychiatry.  5:864-866. 2018
    2018 Lamivudine monotherapy as a holding regimen for HIV-positive children.  PLoS ONE.  13. 2018
    2018 No Impact of Hepatitis B Virus Infection on Early Mortality among Human Immunodeficiency Virus-Infected Patients in Southern Africa.  Clinical Infectious Diseases.  67:1310-1311. 2018
    2018 HIV Self-Testing in Lusaka Province, Zambia: Acceptability, Comprehension of Testing Instructions, and Individual Preferences for Self-Test Kit Distribution in a Population-Based Sample of Adolescents and Adults.  AIDS Research and Human Retroviruses.  34:254-260. 2018
    2018 Retention and mortality on antiretroviral therapy in sub-Saharan Africa: Collaborative analyses of HIV treatment programmes: Collaborative.  Journal of the International AIDS Society.  21. 2018
    2018 Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology.  77:413-416. 2018
    2018 Chronic hepatitis B virus monoinfection at a university hospital in Zambia.  World Journal of Hepatology.  10:622-628. 2018
    2018 Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.  Journal of Clinical Virology.  98:5-7. 2018
    2018 Hepatitis B virus contact disclosure and testing in Lusaka, Zambia: A mixed-methods study.  BMJ Open.  8. 2018
    2018 Point-of-care urine ethyl glucuronide testing to detect alcohol use among HIV-hepatitis B virus coinfected adults in Zambia.  AIDS and Behavior.  22:2334-2339. 2018
    2018 Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.  Pediatric Infectious Disease Journal.  37:103-107. 2018
    2018 Rifaximin reduces markers of inflammation and bacterial 16S rRNA in Zambian adults with hepatosplenic schistosomiasis: A randomized control trial.  American Journal of Tropical Medicine and Hygiene.  98:1152-1158. 2018
    2017 Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.  BMC Infectious Diseases.  17. 2017
    2017 Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers.  Transactions of The Royal Society of Tropical Medicine and Hygiene.  111:425-432. 2017
    2017 Risk factors for impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia.  Journal of Diabetes & Metabolic Disorders.  16. 2017
    2017 Impact of Antiretroviral Therapy on Liver Fibrosis among Human Immunodeficiency Virus-Infected Adults with and Without HBV Coinfection in Zambia.  Clinical Infectious Diseases.  64:1343-1349. 2017
    2017 Awareness and management of elevated blood pressure among human immunodeficiency virus–infected adults receiving antiretroviral therapy in urban Zambia: A call to action.  Global Health Action.  10:1-5. 2017
    2016 Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.  Tropical Medicine and International Health.  21:1435-1441. 2016
    2016 Kaposi sarcoma risk in HIV-infected children and adolescents on combination antiretroviral therapy from sub-Saharan Africa, Europe, and Asia.  Clinical Infectious Diseases.  63:1245-1253. 2016
    2016 Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.  International Journal of Infectious Diseases.  51:97-102. 2016
    2016 Absence of active hepatitis C virus infection in human immunodeficiency virus clinics in Zambia and Mozambique.  Open Forum Infectious Diseases.  3. 2016
    2016 Corrigendum to "Hepatitis B viral load in dried blood spots: A validation study in Zambia" [J. Clin. Virol. 72 (2015) 20-24] Doi: 10.1016/j.jcv.2015.08.019.  Journal of Clinical Virology.  74:88. 2016
    2016 Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.  PLoS ONE.  11:e0152043. 2016
    2015 Pediatric HIV-HBV coinfection in Lusaka, Zambia: Prevalence and short-term treatment outcomes.  Journal of Tropical Pediatrics.  61:464-467. 2015
    2015 Hepatitis B viral load in dried blood spots: A validation study in Zambia.  Journal of Clinical Virology.  72:20-24. 2015
    2015 Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.  Liver International.  35:1886-1892. 2015
    2015 Implementation of routine screening for chronic hepatitis B virus co-infection by HIV clinics in Lusaka, Zambia.  Journal of Viral Hepatitis.  22:858-860. 2015
    2015 Response to 'Is AST-to-platelet ratio index a reliable tool in HIV patients in Africa?'.  Liver International.  35:2060. 2015
    2015 Validation of medicaid claims-based diagnosis of myocardial infarction using an HIV clinical cohort.  Medical Care.  53:e41-e48. 2015
    2014 Chronic hepatitis B virus coinfection is associated with renal impairment among zambian HIV-infected adults.  Clinical Infectious Diseases.  59:1757-1760. 2014
    2014 Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.  Clinical Infectious Diseases.  58:1473-1480. 2014
    2014 Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.  AIDS Research and Human Retroviruses.  30:949-955. 2014
    2014 Leveraging rapid implementation of an HIV treatment policy to reduce confounding in observational analysis of antiretroviral outcomes.  Tropical Medicine and International Health.  19:499-500. 2014
    2014 Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in Urban Zambia.  AIDS Research and Human Retroviruses.  30:74-77. 2014
    2013 Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern United States.  AIDS Research and Human Retroviruses.  29:1068-1074. 2013
    2013 Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology.  62:505-508. 2013
    2013 Do all candidemic patients need an ophthalmic examination?.  International Journal of Infectious Diseases.  17. 2013
    2012 Clinical scoring for risk of resistant organisms in pneumonia: Right idea, wrong interpretation.  Clinical Infectious Diseases.  55:749-750. 2012
    2011 Herpes simplex virus type 2 mimicking necrotizing fasciitis.  Annals of Internal Medicine.  155:567-568. 2011
    2009 Influenza A virus subtyping: Paradigm shift in influenza diagnosis.  Journal of Clinical Microbiology.  47:3055-3056. 2009

    Research Overview

  • HIV-hepatitis confection
    Global health
    Alcohol use disorder

    • Principal Investigator On

    Investigator On

    Education And Training

  • Doctor of Medicine, Loyola University Chicago 2006
  • Bachelor of Science or Mathematics in Biology, University of Illinois System : Urbana-Champaign 2001
  • Rush Medical College of Rush University, Residency 2010
  • University of North Carolina Hospital Medicine, Postdoctoral Fellowship 2014

    • Full Name

  • Michael Vinikoor